AbbVie Inc. (NYSE:ABBV) entered the obesity race last week when it in-licensed GUB014295 (also called GUBamy) from Denmark-based Gubra. The candidate is a long-acting amylin analog for the ...

AbbVie is navigating significant shareholder activism as it urges opposition to two governance proposals ahead of its May 2025 meeting, fostering investor attention. Despite reporting a Q4 net ...

AbbVie shares recently rebounded, supported by strong earnings, positive guidance, and a late 2024 dividend increase, indicating the potential for further gains. Despite a $3.5 billion impairment ...

BTS' Jin has officially made his acting debut in a new ad and fans are already obsessed with his natural talent BTS' Jin is officially making his acting debut, and fans couldn’t be more excited.

AbbVie’s immunology blockbusters Rinvoq and Skyrizi took the first and second slots, respectively, for the month, resuming the custom they upheld throughout most of 2024. Those gains over ...

Whales with a lot of money to spend have taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie ABBV we detected 29 trades. If we consider the specifics of each trade ...

Jin, fondly known among fans as Worldwide Handsome, of the K-pop supergroup BTS, sat in the front row at Gucci‘s fall 2025 fashion show in Milan on Tuesday. BTS member Jin (aka Kim Seokjin ...

AbbVie’s former CEO Richard Gonzalez—who collected a $25.7 million payout for his final full year on the job in 2023—often ranked among the industry’s highest-paid CEOs during his tenure.

Emily Feng is an award-winning correspondent for NPR covering China, Taiwan and beyond, reporting on everything from semiconductors to drones, environmental wastelands to girl bands. Formerly based in ...

AbbVie has signed a licensing deal with Danish-based Gubra to develop an obesity drug, marking the North Chicago company's first foray into the obesity market. Gubra will receive $350 million ...

We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best DRIP stocks to own now.

After its world premiere at the Toronto International Film Festival in 2023 and playing other fests through the past year, Hur Jin-ho‘s “A Normal Family” will touch down in North America in ...